Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    19850138 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Creatine Safety and Tolerability in Premanifest HD: PRECREST
Condition: Huntington Disease
Interventions: Drug: Creatine monohydrate;   Drug: Placebo
2 Completed Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study
Condition: Huntington's Disease
Intervention: Drug: Creatine Monohydrate

Indicates status has not been verified in more than two years